Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
HIMS
HIMS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
HIMS News
HIMS CEO Emphasizes Long-Term Execution Amid Stock Volatility
2d ago
stocktwits
Investment Choices: Hims & Hers vs. Teladoc
1d ago
NASDAQ.COM
Investment Comparison Between Hims & Hers and Teladoc
1d ago
Fool
United Therapeutics Corp Sees Surge in Options Trading Volume
1d ago
NASDAQ.COM
Hims & Hers Secures $400M Financing Agreement with JPMorgan Chase
6d ago
stocktwits
FDA Revives Advisory Committee Meetings for Drug Approvals
6d ago
seekingalpha
HIMS Faces Negative Impact from FDA's Peptide Recommendation
6d ago
Newsfilter
FDA Challenges Seven Popular Peptides Amid Safety Concerns
Jul 01 2026
stocktwits
Hims & Hers Health Inc. Stock Fluctuations
Jun 29 2026
NASDAQ.COM
Restaurant Brands International Options Volume Surges
Jun 26 2026
NASDAQ.COM
Estrogen Patch Shortage Impacts Hormone Therapy
Jun 26 2026
CNBC
Hims Partners with Novo Nordisk to Offer Weight-Loss Drugs
Jun 26 2026
stocktwits
HIMS CMO Plans to Sell Shares Amid Positive Market Trends
Jun 22 2026
stocktwits
Hims & Hers Partners with Novo Nordisk, Boosting Stock Momentum
Jun 17 2026
stocktwits
Hims & Hers Faces Key Regulatory Meeting on Peptides
Jun 17 2026
stocktwits
Hims' Peptide Market Outlook for the Next Decade
Jun 16 2026
stocktwits
Show More News
